Organon (OGN) Debt Ratio (2020 - 2026)
Organon (OGN) posted Debt Ratio of 0.65 for Q2 2026, down 0.9% on a QoQ basis from 0.66 in Q1 2026, and down 1.92% year-over-year from 0.67 in Q2 2025.
Analysis
Organon (OGN) Debt Ratio (2020 - 2026) Analysis & Trends
Organon has reported Debt Ratio for 7 years, with the latest figure at 0.65 in Q2 2026.
- On a quarterly basis, Debt Ratio fell 1.92% year-over-year to 0.65 in Q2 2026; TTM through Jun 2026 was 0.65, a 1.92% decrease from a year earlier, with the FY2025 full-year figure at 0.67, down 1.07% from the prior year.
- Debt Ratio was 0.65 for Q2 2026 at Organon, down from 0.66 in the prior quarter.
- The five-year high for Debt Ratio was 0.86 in Q1 2022, with the low at 0.65 in Q2 2026.
- Average Debt Ratio over 5 years is 0.74, with a median of 0.72 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio soared 445.27% in 2022, then slipped 12.68% in 2024.
- Over 5 years, Debt Ratio stood at 0.81 in 2022, then fell by 10.62% to 0.73 in 2023, then decreased by 6.52% to 0.68 in 2024, then declined by 1.07% to 0.67 in 2025, then retreated by 2.73% to 0.65 in 2026.
- The last three Debt Ratio figures came in at 0.65 (Q2 2026), 0.66 (Q1 2026), and 0.67 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 0.30 |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 0.08 |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 0.17 |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 0.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 0.65 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.65 |
| Mar 31, 2026 | 0.66 |
| Dec 31, 2025 | 0.67 |
| Sep 30, 2025 | 0.65 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.68 |
| Dec 31, 2024 | 0.68 |
| Sep 30, 2024 | 0.69 |
| Jun 30, 2024 | 0.71 |
| Mar 31, 2024 | 0.73 |
| Dec 31, 2023 | 0.73 |
| Sep 30, 2023 | 0.79 |
| Jun 30, 2023 | 0.80 |
| Mar 31, 2023 | 0.81 |
| Dec 31, 2022 | 0.81 |
| Sep 30, 2022 | 0.83 |
| Jun 30, 2022 | 0.84 |
| Mar 31, 2022 | 0.86 |
| Dec 31, 2021 | 0.86 |
| Sep 30, 2021 | 0.82 |